glp 1 drugs stocks The Obesity Drug Boom GLP-1 Receptor Agonist Market Size
Description
Colorados Attorney General joined a lawsuit with 36 other states earlier this year, urging the FDA to enforce regulations surrounding compounded GLP-1s as well as cracking down on counterfeit versions of the drug
HR = 0.73
Nat Rev Endocrinol (2019) 15:28898
There have been reports of people accidentally taking a much larger dose than intended of compounded semaglutide or tirzepatide, leading to side effects like nausea, vomiting, and diarrhea sometimes so severe that they required hospitalization
